The plasma membrane presents a remarkable barrier for the delivery of peptide and nucleic acid based drugs to the inside of cells This restraint in the path of their development as therapeutic agents can be offset by their conjugation to cell penetrating peptides (CPPs) that can lead to an improved pharmacological profile